Repeated assessment of physical biomeasures or blood biomarkers for the definition of volume status and cardiac loading in LVSD.
The application of biomarker technology can be usefully implemented in areas where current techniques are inadequate and where a clinical issue, which affects outcome, can be defined. The definition of the loading status of the heart where there is pre-existent impairment of contractile function is a key target. Heart failure is a complex clinical presentation with many varied etiologies, but at the essence of its successful management is the reliable definition of cardiac volume loading. Traditional and many current technological measures are applied to define this relationship, yet their accuracy and performance in individual patients is either basically inadequate or poorly understood and applied. There is a wide range of both physical measurements and blood biomarkers that can be considered to better define this key issue in patients with ventricular systolic impairment. Their performance is considered in detail in this review.
Chuen
Marie Jennyfer Ng Kam
MJ
University Department of Medicine, City Hospital, Dudley Road, Birmingham, B18 7QH England, UK.
Lip
Gregory Y H
GY
MacFadyen
Robert J
RJ